The immune regulatory capacity of released galanin and its receptors was proven in various animal models of inflammatory diseases, including inflammatory bowel disease (IBD), arthritis, dermatitis, psoriasis and pancreatitis28–34. Here, GAL is linked to arthritic joint disease.